| [1] |
Kirnbauer R, Schellenbacher C, Shafti-Keramat S, et al. HPV infections of the oral and genital mucosa. Possibilities for primary prevention[J]. Hautarzt, 2009, 60(11):878-880.
|
| [2] |
Mougin C, Bourgault-Villada I, Coursaget P. HPV immunization for the prevention of cervical cancer[J]. Presse Med, 2009, 38(12):1750-1768.
|
| [3] |
Münger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis[J]. J Virol, 2004, 78(21):11451-11460.
|
| [4] |
Horvath CA, Boulet GA, Renoux VM, et al. Mechanisms of cell entry by human papillomaviruses: An overview[J]. Virol J, 2010, 7:11.
|
| [5] |
Li S, Meng YH, Ting H, et al. Clinical significance of human papilloma virus infection in the cervical lesions[J]. Frontiers Med China, 2010, 4(3):264-270.
|
| [6] |
Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type specific implications in cervical neoplasia[J]. Vaccine, 2008, 26(10):K1-K16.
|
| [7] |
Bao YP, Li N, Smith JS, et al. Human papilloma virus type distribution in the cervix of Chinese women: A meta-analysis[J]. Int J STD AIDS, 2008, 19(2):106-111.
|
| [8] |
Chen W, Zhang X, Molijn A, et al. Human papilloma virus type-distribution in cervical cancer in china: The importance of HPV 16 and 18[J]. Cancer Causes Control, 2009, 20(9):1705-1713.
|
| [9] |
Ames A, Gravitt P. Human papilloma virus vaccine update[J]. Curr Infect Dis Rep, 2007, 9(2):151-158.
|
| [10] |
Margaret S. Prophylactic HPV vaccines[J]. J Clin Pathol, 2007, 60(9):961-965.
|
| [11] |
Harper DM, Franco EL, Wheeler C. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papilloma virus types 16 and 18 in young women: A randomised controlled trial[J]. Lancet, 2004, 364(9447):1757-1765.
|
| [12] |
Qi QP, Luo XW, Gan YJ, et al. A Meta-analysis of the effects of prophylactic human papillomavirus vaccination on prevention of cervical cancer[J]. Chin Gen Pract, 2011, 14(8B):2641-2643.
|
| [14] |
Fraillery D, Baud D, Pang SY, et al. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever[J]. Clin Vaccine Immunol, 2007, 14(10):1285-1295.
|
| [15] |
Schellenbacher C, Roden R, Kirnbauer R. Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines[J]. J Virol, 2009, 83(19):10085-10095.
|
| [16] |
Cho HJ, Oh YK, Kim YB. Advances in human papilloma virus vaccines: A patent review[J]. Expert Opin Ther Pat, 2011, 21(3):295-309.
|